Literature DB >> 6236875

Photodynamic inactivation of selected intracellular enzymes by hematoporphyrin derivative and their relationship to tumor cell viability in vitro.

R Hilf, N W Warne, D B Smail, S L Gibson.   

Abstract

The photosensitivity of freshly dissociated R3230AC mammary adenocarcinoma cells was examined by measurement of the activities of selected intracellular enzymes after treatment with hematoporphyrin derivative (Hpd) and exposure to light in vitro. Enzymes selected as representative of the cytosolic cell compartment showed no loss in activity, whereas malate dehydrogenase, located in the mitochondrial matrix, displayed a modest decrease (approximately 15%) in activity. In contrast, cytochrome c oxidase and succinate dehydrogenase, enzymes associated with the mitochondrial membrane, demonstrated a very rapid and more marked inhibition of activities, approximately 45% and 25%, respectively. The time-course of inhibition of these mitochondrial membrane enzymes preceded the loss of cell viability, which displayed slower kinetics as seen by a more gradual and progressive pattern of loss in viability. These data suggest that the mitochondria are an early-affected and important intracellular site for Hpd photosensitization.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236875     DOI: 10.1016/0304-3835(84)90132-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Tumor viability using real-time spectral images.

Authors:  Koji Asai; Yoshinobu Sumiyama; Manabu Watanabe; Katsuo Aizawa
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

Review 2.  Adjuvant therapy for pituitary adenomas: the possible role of photodynamic therapy.

Authors:  P V Marks
Journal:  Ann R Coll Surg Engl       Date:  1995-07       Impact factor: 1.891

Review 3.  Photodynamic therapy--achievements and prospects.

Authors:  D Ash; S B Brown
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.